Chronic lung allograft dysfunction after lung transplantation: the moving target
- PMID: 23138970
- DOI: 10.1007/s11748-012-0167-3
Chronic lung allograft dysfunction after lung transplantation: the moving target
Abstract
Chronic lung allograft dysfunction is a major challenge in long-term management of lung transplant recipients. Both alloimmune-dependent factors (rejection) and alloimmune-independent factors contribute to the development of chronic lung allograft dysfunction. Thus, use of the term "chronic rejection" tends to be intentionally avoided among specialists in the field, although "chronic rejection" is still an acceptable lay word understood by many patients. Several different phenotypes have been identified in chronic lung allograft dysfunction, including restrictive allograft syndrome, neutrophilic reversible allograft dysfunction, and fibrous bronchiolitis obliterans syndrome. Restrictive allograft syndrome is characterized by restrictive physiology and peripheral foci of inflammation and fibrosis, which contrasts the obstructive physiology and pathological foci in small airways in conventional bronchiolitis obliterans syndrome. Among patients with bronchiolitis obliterans syndrome, there is a subpopulation that responds relatively well to azithromycin. Because these patients show airway neutrophilia, this subtype of chronic lung allograft dysfunction was named neutrophilic reversible allograft dysfunction. Conversely, patients with bronchiolitis obliterans syndrome unresponsive to azithromycin show airway fibrosis with less inflammation (fibrous bronchiolitis obliterans syndrome). In general, restrictive allograft syndrome shows poorer survival than does bronchiolitis obliterans syndrome, and early-onset bronchiolitis obliterans syndrome (within 2 years) shows a worse prognosis than does late-onset bronchiolitis obliterans syndrome. Until preventive and therapeutic options are refined, chronic lung allograft dysfunction will remain a major life-limiting factor. It has significant psychological, physical, social, and economic impacts. Early introduction of palliative care is another important strategy to improve patients' quality of life.
Similar articles
-
Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation.J Heart Lung Transplant. 2010 Oct;29(10):1159-64. doi: 10.1016/j.healun.2010.05.012. Epub 2010 Jun 26. J Heart Lung Transplant. 2010. PMID: 20580267
-
Lung volumes predict survival in patients with chronic lung allograft dysfunction.Eur Respir J. 2017 Apr 12;49(4):1601315. doi: 10.1183/13993003.01315-2016. Print 2017 Apr. Eur Respir J. 2017. PMID: 28404648
-
Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.J Heart Lung Transplant. 2011 Jul;30(7):735-42. doi: 10.1016/j.healun.2011.01.712. Epub 2011 Mar 17. J Heart Lung Transplant. 2011. PMID: 21419659
-
The contribution of airway ischemia and vascular remodelling to the pathophysiology of bronchiolitis obliterans syndrome and chronic lung allograft dysfunction.Curr Opin Organ Transplant. 2010 Oct;15(5):558-62. doi: 10.1097/MOT.0b013e32833e1112. Curr Opin Organ Transplant. 2010. PMID: 20693899 Review.
-
High-Resolution CT Findings of Obstructive and Restrictive Phenotypes of Chronic Lung Allograft Dysfunction: More Than Just Bronchiolitis Obliterans Syndrome.AJR Am J Roentgenol. 2018 Jul;211(1):W13-W21. doi: 10.2214/AJR.17.19041. Epub 2018 May 24. AJR Am J Roentgenol. 2018. PMID: 29792746 Review.
Cited by
-
Blood Gene Expression Predicts Bronchiolitis Obliterans Syndrome.Front Immunol. 2018 Jan 11;8:1841. doi: 10.3389/fimmu.2017.01841. eCollection 2017. Front Immunol. 2018. PMID: 29375549 Free PMC article.
-
Graft dysfunction and rejection of lung transplant, a review on diagnosis and management.Clin Respir J. 2022 Jan;16(1):5-12. doi: 10.1111/crj.13471. Epub 2022 Jan 25. Clin Respir J. 2022. PMID: 35080130 Free PMC article. Review.
-
Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.Am J Respir Crit Care Med. 2014 Jan 15;189(2):159-66. doi: 10.1164/rccm.201306-1155OC. Am J Respir Crit Care Med. 2014. PMID: 24325429 Free PMC article.
-
Prophylactic azithromycin for chronic lung allograft dysfunction following lung transplantation: a systematic review and meta-analysis.J Thorac Dis. 2025 Jul 31;17(7):4395-4408. doi: 10.21037/jtd-2025-365. Epub 2025 Jul 21. J Thorac Dis. 2025. PMID: 40809223 Free PMC article.
-
The role of innate immunity in the long-term outcome of lung transplantation.Ann Transl Med. 2020 Mar;8(6):412. doi: 10.21037/atm.2020.03.20. Ann Transl Med. 2020. PMID: 32355856 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical